Cancer clinical trials in the region Pays de la Loire
174 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT03175224
Locally Advanced
Metastatic
MET
EGFR
BRAF
ALK
RET
ROS-1
NTRK-1/2/3
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Lung cancer
#NCT03175224
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MET
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
EGFR
BRAF
ALK
RET
ROS-1
NTRK-1/2/3
KRAS G12C
KRAS non G12C
Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Colon cancer
Rectal cancer
#NCT03175224
Locally Advanced
Metastatic
MET
BRAF
RET
NTRK-1/2/3
KRAS G12C
KRAS non G12C
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Universitaire de Lille (Lille), Centre Léon Bérard (Lyon), CHU de Rennes - Hôpital Pontchaillou (Rennes), Gustave Roussy (Villejuif), Hôpital de la Timone AP-HM (Marseille) (and 2 more...)
Apollomics
Phase 2
Kidney cancer
#NCT03967522
Metastatic
Centre Hospitalier Universitaire de Besançon (Besançon), Gustave Roussy (Villejuif), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Bordeaux (Bordeaux) (and 7 more...)
Centre Léon Bérard
Phase 2
Lung cancer
#NCT05635708
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Negative (< 1%)
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
EGFR
BRAF
ALK
RET
ROS-1
Immunotherapy
Institut Curie - Paris (Paris), Centre Hospitalier Universitaire Laennec (Saint-Herblain)
BeiGene
Phase 2
Lymphoma
#NCT04984837
T cell lymphoma
Peripheral T cell lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
Systemic Treatment-Naive
Allogeneic stem cell transplant
CHU Amiens-Picardie (site sud) (Amiens), Hôpital Claude Huriez (Lille), Hôpital Necker Enfants malades - AP-HP (Paris ), Centre Hospitalier de Perpignan (Perpignan), Centre Henri Becquerel (Rouen ) (and 38 more...)
Organisation de recherche universitaire sur le lymphome
Phase 2
Lymphoma
#NCT05660967
B cell lymphoma
Large B cell lymphoma
CD20
None
Systemic Treatment-Naive
None
Autologous stem cell transplant
Allogeneic stem cell transplant
Car-T
Centre Hospitalier Universitaire Angers (Angers ), CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Saint Louis AP-HP (Paris), Centre Hospitalier Régional Universitaire de Tours (Tours), CHU Amiens-Picardie (site sud) (Amiens) (and 5 more...)
Genmab
Phase 2
Lymphoma
#NCT04974216
B cell lymphoma
Large B cell lymphoma
Follicular lymphoma
Indolent transformed lymphoma
CD20
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
Systemic Treatment-Naive
None
Centre Antoine Lacassagne (Nice), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Centre Hospitalier Universitaire Dupuytren (Limoges), Hôpital Saint Vincent-De-Paul (Lille), Institut Bergonié (Bordeaux) (and 7 more...)
Organisation de recherche universitaire sur le lymphome
Phase 2
Lymphoma
#NCT04104776
B cell lymphoma
Large B cell lymphoma
None
Treated / Controled
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 2
Lymphoma
#NCT04920617
B cell lymphoma
Large B cell lymphoma
Indolent transformed lymphoma
None
Treated / Controled
Chemotherapy
Targeted therapy
2
3 or more
Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice), Hôpital Pitié Salpêtrière - AP-HP (Paris), Hôpital Saint Antoine AP-HP (Paris), CHU - Haut-lévêque - Bordeaux (Pessac), Hôpital Privé du Confluent - Vivalto Santé (Nantes) (and 5 more...)
ImmunoVaccine Technologies, Inc.